Literature DB >> 6132592

CSF somatostatin in affective illness.

D R Rubinow, P W Gold, R M Post, J C Ballenger, R Cowdry, J Bollinger, S Reichlin.   

Abstract

Somatostatin is a hypothalamic tetradecapeptide with many actions. We investigated a potential role for somatostatinergic neuron dysfunction in affective disorder by measuring somatostatin in the CSF of 47 patients with affective illness and of 39 normal volunteers. Medication-free depressed patients showed significantly lower levels of CSF somatostatin than normal volunteers (P less than .001) or patients during the improved state (P less than .01). A significant inverse correlation was observed between somatostatin and the duration of sleep on the night of the lumbar puncture. We also observed significant correlations between somatostatin and 5-hydroxyindoleacetic acid and norepinephrine in the CSF. Also noted were the significance of depression-related decreases in CSF somatostatin in relation to information about central somatostatin secretion, reported abnormalities of somatostatin activity, and potential interactions between alterations in somatostatin activity and the pathophysiology of depression.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6132592     DOI: 10.1001/archpsyc.1983.01790040063009

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  18 in total

1.  Somatostatin content and receptors in the cerebral cortex of depressed and control subjects.

Authors:  B G Charlton; A Leake; C Wright; A F Fairbairn; I G McKeith; J M Candy; I N Ferrier
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-05       Impact factor: 10.154

2.  GABA-related transcripts in the dorsolateral prefrontal cortex in mood disorders.

Authors:  Etienne Sibille; Harvey M Morris; Rama S Kota; David A Lewis
Journal:  Int J Neuropsychopharmacol       Date:  2011-07       Impact factor: 5.176

3.  Effect of carbamazepine on mean urinary free cortisol excretion in patients with major affective illness.

Authors:  D R Rubinow; R M Post; P W Gold; T W Uhde
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

4.  Effects of carbamazepine on cerebrospinal fluid somatostatin.

Authors:  D R Rubinow; R M Post; P W Gold; J C Ballenger; S Reichlin
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

5.  Somatostatin cerebrospinal fluid levels in dementia.

Authors:  A Molins; R Catalán; J Sahuquillo; J M Castellanos; A Codina; R Galard
Journal:  J Neurol       Date:  1991-06       Impact factor: 4.849

6.  Lack of effect of chronic carbamazepine on brain somatostatin in the rat.

Authors:  S R Weiss; T Nguyen; D R Rubinow; C J Helke; P K Narang; R M Post; D M Jacobowitz
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

Review 7.  Involvement of brain catecholamines and acetylcholine in growth hormone hypersecretory states. Pathophysiological, diagnostic and therapeutic implications.

Authors:  E E Müller; M Rolla; E Ghigo; D Belliti; E Arvat; A Andreoni; A Torsello; V Locatelli; F Camanni
Journal:  Drugs       Date:  1995-11       Impact factor: 9.546

8.  Predator stress induces behavioral inhibition and amygdala somatostatin receptor 2 gene expression.

Authors:  S A Nanda; C Qi; P H Roseboom; N H Kalin
Journal:  Genes Brain Behav       Date:  2008-03-21       Impact factor: 3.449

9.  Neuropeptides involved in the pathophysiology of schizophrenia and major depression.

Authors:  David De Wied; Hein O. Sigling
Journal:  Neurotox Res       Date:  2002 Aug-Sep       Impact factor: 3.911

Review 10.  Psychoneuroendocrine research in depression. II. Hormonal responses to releasing hormones as a probe for hypothalamic-pituitary-endorgan dysfunction.

Authors:  K P Lesch; R Rupprecht
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.